Manuscripts
Showing 1533 manuscripts.
No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.
Citation
Rajesh Gandhi, Ronald J. Bosch, Evgenia Aga, Mary Albrecht, Lisa M. Demeter, Carrie Dykes, Barbara Bastow, Michael F. Para, J. P. Lai, Robert F. Siliciano, Janet M. Siliciano, Joseph J. Eron. No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.. Journal of Infectious Diseases. 2010. 201: 293-6. PMID: 20001856Year
2010
Journal
Journal of Infectious Diseases
Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate
Citation
Athe Tsibris. Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate. Journal of Acquired Immune Deficiency Syndromes. 2010. 55: 420-7. PMID: 20856130Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens
Citation
Kenneth E. Sherman, Susan D. Rouster, S. Stanford, Jason T. Blackard, Norah Shire, Margaret James Koziel, Marion G. Peters, Raymond T. Chung. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. Journal of Infectious Diseases. 2010. 201: 712-9. PMID: 20105080Year
2010
Journal
Journal of Infectious Diseases
Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG protocol A5051, a rollover trial of ACTG protocol A328)
Citation
Ronald J. Bosch, Richard B. Pollard, Alan Landay, Evgenia Aga, Lawrence Fox, Ronald T. Mitsuyasu. Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG protocol A5051, a rollover trial of ACTG protocol A328). AIDS Research & Therapy (online journal). 2010. 7: 30. PMID: 20687947Year
2010
Journal
AIDS Research & Therapy (online journal)
Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort.
Citation
Kevin R. Robertson. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort.. Neurology. 2010. 74: 1260-6. PMID: 20237308Year
2010
Journal
Neurology
Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants
Citation
Jaime G Deville, Mark Mirochnick, Gwendolyn B Scott, Lynne M Mofenson, Jennifer S Read, Rolando M Viani, Sandra K Burchett, Ellen R Cooper, Renee Browning, David E Shapiro, Susan B Brogly, Marc Foca. Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants. Journal of Acquired Immune Deficiency Syndromes. 2010. 53: 154-7. PMID: 20035168Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1025
Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected children as compared to controls living in HIV-affected households.
Citation
Leslie Serchuck, Paige L. Williams, Sharon Appelbaum Nachman, Kenneth D. Gadow, Miriam Chernoff, Lynnae Schwartz. Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected children as compared to controls living in HIV-affected households.. AIDS Care. 2010. 22PMID: 20401767Year
2010
Journal
AIDS Care
Study
P1055
Lopinavir tablet pharmacokinetics with an increased dose during pregnancy
Citation
Mark Mirochnick, ChengCheng Hu, Sandra K Burchett, Steven S Rossi, Elizabeth Smith, Jennifer S Read, Edmund V Capparelli, International Maternal Pediatric Adolescent AIDS Clinical Trials Group 1026s Study Team, Brookie M Best, Alice M Stek, Hong Li. Lopinavir tablet pharmacokinetics with an increased dose during pregnancy. Journal of Acquired Immune Deficiency Syndromes. 2010. 54: 381-8. PMID: 20632458Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals
Citation
Ming Lu, David E Shapiro, Ronald C Hershow, Audrey L French, Robert M Leighty, Bruce Thompson, Ruth E Tuomala, David W Ouyang, Susan Brogly. Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals. AIDS. 2010. 24: 109-14. PMID: 19926957Year
2010
Journal
AIDS
Study
P1025
Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy
Citation
Susan B Brogly, Elizabeth G Livingston, Alice M Stek, Arlene D Bardeguez, Ruth E Tuomala, Kunjal Patel, David E Shapiro. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. Journal of Infectious Diseases. 2010. 201: 1035-44. PMID: 20196654Year
2010
Journal
Journal of Infectious Diseases
Study
P1025